 |
인쇄하기
취소
|
Reckitt Benckiser Korea releases Gaviscon
Reckitt Benckiser Korea, a Korean unit of UK based Reckitt Benckiser plc, says it has recently launched Gasviscon, a non-prescription medication for the treatment of heartburn and GERED/(also known as GORD) (acid reflux).
Gaviscon is taken to treat heartburn, similar to other antacids. Gaviscon is based on a mixture of the buffering agents and neutalizers calcium carbonate and sodium bicarbo...
Gaviscon is taken to treat heartburn, similar to other antacids. Gaviscon is based on a mixture of the buffering agents and neutalizers calcium carbonate and sodium bicarbo...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.